What is CHRODIS PLUS Joint Action?

CHRODIS PLUS is a three-year initiative (2017-2020) led by the Institute of Health Carlos III and is being funded by the European Commission and the participating parties.

Europe is paying a heavy price for chronic diseases: it has been estimated that chronic diseases cost EU economies 115 billion € or 0.8% of GDP annually. Approximately 70% to 80% of health care budgets across the EU are spent on treating chronic diseases. CHRODIS PLUS during its 36 months of operation will contribute to the reduction of this burden by promoting the implementation of policies and practices with demonstrated success. The development and sharing of these tested policies and projects across EU countries is the core idea driving this action. Reducing the burden of chronic diseases like diabetes, cardiovascular disease, cancer and mental disorders is a priority of EU Member States and at the EU Policy level, since they affect 8 out of 10 people aged over 65 in Europe. 
 There is a wealth of knowledge within EU Member States on effective and efficient ways to prevent and manage cardiovascular disease, stroke and diabetes type-2. There is great potential to reduce the burden of chronic disease by making better use of this knowledge.

This Joint Action raises the awareness that in a health-promoting Europe – free of preventable chronic diseases, premature death and avoidable disability – initiatives on chronic diseases should build on four cornerstones:

  1. health promotion and primary prevention as a way to reduce the burden of chronic diseases
  2. patient empowerment
  3. tackling functional decline and quality of life as the main consequences of chronic diseases
  4. making health systems sustainable and responsive to the aging of our populations associated with the epidemiological transition

The objective of Joint Actions

Joint Actions are a funding instrument under the third EU Health Programme 2014-2020. They are designed and financed by Member State authorities and the EU to address specific priorities under the EU Health Programme.  They have a clear EU added value and are co-financed either by competent authorities that are responsible for health in the Member States (e.g. Health Ministries) or in the third countries participating in the Programme, or by public sector bodies and non-governmental bodies mandated by those competent authorities.

Joint Actions involve on average 25 partners, depending on the scope of the action. This joint action involves representatives of the 42 participant institutions – from 18 EU countries plus Norway, Serbia and Iceland.

The Joint Action supports Member States through cross-national implementation of policies and practices with demonstrated success identified in the JA-CHRODIS (2013-2016).

Altogether 16 policy dialogues and 22 pilot implementations form the core of the Action:

  • The policy dialogues (14 at national level, and 2 at EU level) raise awareness and acceptance in decision makers on improved actions to combat chronic diseases.
  • The pilot projects focus on the following areas: Health promotion & primary prevention, Integrated Multimorbidity care model, Fostering quality of care for people with chronic diseases, ICT based patient empowerment and Employment & chronic diseases.

Joint Action CHRODIS (2013-2016)

This Joint Action was the predecessor of CHRODIS PLUS.

JA-CHRODIS was a European collaboration that brought together over 70 associated and collaborating partners from e.g. national and regional departments of health and research institutions, from 25 European countries. These partners worked together to identify, validate, exchange and disseminate good practice on chronic diseases across EU Member States and to facilitate its uptake across local, regional and national borders. The focus is health promotion and primary prevention as well as the management of diabetes and multi-morbid chronic conditions

One of the key deliverables was a ‘Platform for Knowledge Exchange’, which includes both an online help-desk for policy makers and a clearinghouse providing an up to date repository of best practices and the best knowledge on chronic care.

Joint Action CHRODIS at a glance – find out the most important facts about the Joint Action CHRODIS here.

What is the European Commission’s role?

The EU supports Member States by  providing a comprehensive approach to tackle chronic diseases in Europe. See more about the Directorate General for Health and Consumers’ (DG SANCO) work on chronic diseases.

Click here for more information on EU initiatives relevant to JA-CHRODIS.

The Consumers, Health and Food Executive (Chafea) implements the EU Consumer Programme and the Better Training for Safer Food initiative as well as the EU Health Programme, which co-funds this Joint Action.

The Agency provides a professional service in performing the tasks and activities entrusted to it by the European Commission, and it works closely with the Health and Consumers Directorate General (DG SANCO). CHAFEA manages relations with some 2800 beneficiaries and contractors involved in close to 400 projects and service contracts in the field of health.

JA-CHRODIS will work in close collaboration with the European Innovation Partnership on Active and Healthy Ageing.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt